✦ LIBER ✦

Obesity and the Endocannabinoid System: Is There Still a Future for CB1Antagonists in Obesity?

✍ Scribed by Antonia Serrano, Francisco Javier Pavon, Juan Suarez, Miguel Romero-Cuevas, Elena Baixeras, Pilar Goya, Fernando Rodríguez de Fonseca

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is there a place for incretin therapies

✍ Holst, Jens Juul; Deacon, Carolyn F. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 351 KB

The Endocannabinoid System as a Target f

✍ IOANNIS KYROU; GEORGE VALSAMAKIS; CONSTANTINE TSIGOS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB

Cardiovascular risk in aging and obesity

✍ Gola, M.; Bonadonna, S.; Doga, M.; Mazziotti, G.; Giustina, A. 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 128 KB

Sleep, obesity, and weight loss in adult

✍ Coughlin, Janelle W.; Smith, Michael T. 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 115 KB

Is There a Rationale for Angiotensin Blo

✍ Sharma, A. M. 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 353 KB

Development of a Practical and Efficient

✍ Ragan, John A.; Bourassa, Dennis E.; Blunt, Jon; Breen, Darragh; Busch, Frank R. 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 1007 KB